All Stories

  1. Molecular biologic milieu in rhegmatogenous retinal detachment and proliferative vitreoretinopathy: a literature review
  2. The importance of aerobic capacity and nutrition in recreational master mountain runners’ performance and race-induced changes in body composition and biochemical blood indices
  3. Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
  4. Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease
  5. Validation and verification of examination procedures in medical laboratories: opinion of the EFLM Working Group Accreditation and ISO/CEN standards (WG-A/ISO) on dealing with ISO 15189:2012 demands for method verification and validation
  6. Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system
  7. Frontotemporal dementia spectrum: first genetic screen in a Greek cohort
  8. Th17 serum cytokines in relation to laboratory‐confirmed respiratory viral infection: A pilot study
  9. Documenting metrological traceability as intended by ISO 15189:2012: A consensus statement about the practice of the implementation and auditing of this norm element
  10. A pilot plasma-ctDNA ring trial for the Cobas® EGFR Mutation Test in clinical diagnostic laboratories
  11. Lazaroid (U-74389G) ameliorates lung injury due to lipid peroxidation and nitric oxide synthase-dependent reactive oxygen species generation caused by remote systematic ischemia-reperfusion following thoracoabdominal aortic occlusion
  12. Brain-derived neurotrophic factor (BDNF) in children with ASD and their parents: a 3-year follow-up
  13. Response to the letter to editor: Copeptin and its clinical implications in the setting of vasovagal syncope
  14. Investigation of associations of ARMS2, CD14, and TLR4 gene polymorphisms with wet age-related macular degeneration in a Greek population
  15. Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
  16. Copeptin levels in patients with vasovagal syncope
  17. AKT2 Gene Polymorphisms, sRANKL/OPG and Hormone Measurements in Polycystic Ovarian Syndrome (PCOS) Women
  18. Development and validation of molecular methodologies to assess PALB2 expression in sporadic breast cancer
  19. Accreditation process in European countries – an EFLM survey
  20. Recommendation for the review of biological reference intervals in medical laboratories
  21. Circulating resistin is a significant predictor of mortality independently from cardiovascular comorbidities in elderly, non-diabetic subjects with chronic kidney disease
  22. Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: Analytical performance and establishment of reference values
  23. Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer
  24. Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens
  25. Non-invasive prenatal testing (NIPT): limitations on the way to become diagnosis
  26. Novel association of FCGR2A polymorphism with age-related macular degeneration (AMD) and development of a novel CFH real-time genotyping method
  27. Flexible Scope for ISO15189 accreditation
  28. Oxidative stress in dry age-related macular degeneration and exfoliation syndrome
  29. Validation of a Real-Time Quantitative Polymerase Chain Reaction Method for the Quantification of 3 Survivin Transcripts and Evaluation in Breast Cancer Tissues
  30. Association of survivin splice variants with prognosis and treatment of breast cancer
  31. Molecular Genetics of Pseudoexfoliation Syndrome (PXFS) and Glaucoma(PXFG)
  32. Serum markers of deranged myocardial collagen turnover: Their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure
  33. Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
  34. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
  35. Biomarkers in primary open angle glaucoma
  36. Human papilloma virus (HPV) molecular diagnostics
  37. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR
  38. Increased inflammatory Response in Patients With Dilated Cardiomyopathy Is Associated With Dyslipidemia: Effects of Statin Therapy
  39. The Association Between a CommonFCGR2APolymorphism and C-Reactive Protein and Coronary Artery Disease Revisited
  40. PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method
  41. P374 EPIGENETIC MODIFICATIONS IN HUMAN CAROTID ATHEROMATOUS PLAQUES
  42. Mutation scanning of exon 20 of the BRCA1 gene by high-resolution melting curve analysis
  43. PI3K Pathway Activity and Response to First-Line Chemotherapy in Combination with Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer.
  44. The Effect of Plasma Homocysteine Levels on Clinical Outcomes of Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome
  45. Development of a real-time PCR detection method for a FCGR2A polymorphism in the LightCycler and application in the heparin-induced thrombocytopenia syndrome
  46. Serum oxidizability, total antioxidant status and albumin serum levels in patients with aneurysmal or arterial occlusive disease
  47. Asymmetric real-time PCR detection of BRCA1 5382insC mutation by melting curve analysis in the LightCycler
  48. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece
  49. The beneficial effects of the combined methods in investigating heparin-induced thrombocytopenia
  50. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics
  51. Antiinflammatory Effects of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure
  52. Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement
  53. Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor Splice Variants
  54. Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA
  55. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy
  56. Genetic counseling of medullary breast cancer patients
  57. P-470 Sustained improvement in peripheral immune responses by biventricular pacing and its association with exercise tolerance and quality of life
  58. P-230 The effect of biventricularpacing on serum levels of soluble cellular adhesion molecules is sustained following 3 months of therapy discontinuation
  59. P-168 BNP in biventricular pacing: Its association with functional status and inflammatory markers
  60. Prognostic significance of soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy
  61. 158 Growth hormone treatment reduces circulating inflammatory cytokines and improves left ventricular contractile performance in patients with dilated cardiomyopathy
  62. Atypical Medullary Breast Carcinoma in a Family Carrying the 5382insC BRCA-1 Mutation
  63. Sustained improvement in peripheral immune response by biventricular pacing and its association with exercise tolerance and quality of life
  64. Physical training-induced reduction of peripheral monocyte-related inflammatory markers is associated with improvement in endothelial function of chronic heart failure patients
  65. Immunomodulatory effects of growth hormone administration are associated with improvement in myocardial contractile performance in dilated cardiomyopathy patients
  66. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed
  67. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy
  68. Physical training modulates proinflammatory cytokines and soluble fas-soluble fas ligand system in patients with chronic heart failure
  69. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure
  70. Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations
  71. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure
  72. Immune-genetic control of hyperprolactinemia in patients with heart failure and correlation with ventricular function Dennis Cokkinos, Constantinos Limas, Christos Kroupis, Antigoni Haidaroglou. Onassis Cardiac Surgery Center, Athens, Greece
  73. Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease
  74. Physical training reduces circulating monocyte-endothelial cell adhesive interaction markers in patients with chronic heart failure
  75. Effects of growth hormone treatment on circulating proinflammatory cytokines and soluble apoptosis receptor Fas in patients with dilated cardiomyopathy
  76. BRCA1 mutation analysis in breast/ovarian cancer families from Greece
  77. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors
  78. Effect of Cyclosporine and Sirolimus on Interleukin-15–Driven Proliferation of OKT3-Preactivated Human Lymphocytes
  79. ATP-dependent Regulation of Sodium-Calcium Exchange in Chinese Hamster Ovary Cells Transfected with the Bovine Cardiac Sodium-Calcium Exchanger
  80. Dimerization of Thermomonospora fusca .beta.-1,4-endoglucanase E2
  81. Cloning and expression of the bovine cardiac sodium-calcium exchanger